スポンサーリンク
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi | 論文
- NAD(P)H : quinone oxidoreductase 1 (NQ01) C609T polymorphism and the risk of eight cancers for Japanese
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Clinical and Oncologic Implications in Epigenetic Down-Regulation of CD26/Dipeptidyl Peptidase IV in Adult T-Cell Leukemia Cells
- Clinical Relevance of Survivin as a Biomarker in Neoplasms, Especially in Adult T-Cell Leukemias and Acute Leukemias
- Identification of Genes Associated with the Progression of Adult T Cell Leukemia (ATL)
- Real-Time Polymerase Chain Reaction for Quantification of HTLV-1 Proviral Load: Application for Analyzing Aberrant Integration of the Proviral DNA in Adult T-Cell Leukemia
- Atomic Bomb and Leukemia : II. BIOLOGICAL EFFECTS
- Physical exercise reduces risk of breast cancer in Japanese women
- Transforming Growth Factor B1 T29C Polymorphism and Breast Cancer Risk in Japanese Women
- Enteropathy-Type Intestinal T-Cell Lymphoma Showing Jejunoileal Fistula: Report of a Case
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Asymptomatic Patients with Acute Leukemias and Malignant Lymphomas Found in Ningen Dock
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Combination of Subareolar Blue Dye and Peritumoral RI for Sentinel Lymph Node Biopsy
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Clinicopathological features of gastric B-cell lymphoma: A series of 317 cases
- Peripheral T-cell lymphoma with a nodular growth pattern
- Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome
- Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
- Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia